BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37357095)

  • 21. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
    Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining Facility Volume Threshold for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Resection of Perihilar Cholangiocarcinoma.
    Elshami M; Hue JJ; Ahmed FA; Kakish H; Hoehn RS; Rothermel LD; Hardacre JM; Ammori JB; Winter JM; Ocuin LM
    J Gastrointest Surg; 2023 Apr; 27(4):730-740. PubMed ID: 36138311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of positive surgical margins after resection of cholangiocarcinoma. Experience at a high-volume hospital center specializing in hepatopancreatobiliary surgery.
    Morales-Cruz M; Armillas-Canseco F; Carpinteyro-Espín P; Domínguez-Rosado I; Mercado MA
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):18-24. PubMed ID: 31685297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Intraoperative Assessment of Proximal Bile Duct Margin Status and Additional Resection of Perihilar Cholangiocarcinoma: Can Local Clearance Trump Tumor Biology? A Retrospective Cohort Study.
    Kawano F; Ito H; Oba A; Ono Y; Sato T; Inoue Y; Mise Y; Saiura A; Takahashi Y
    Ann Surg Oncol; 2023 Jun; 30(6):3348-3359. PubMed ID: 36790733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
    Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
    Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.
    Hammad AY; Berger NG; Eastwood D; Tsai S; Turaga KK; Christian KK; Johnston FM; Pawlik TM; Gamblin TC
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):912-920. PubMed ID: 27654107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of proximal ductal margin status in perihilar cholangiocarcinoma according to the presence or absence of lymph node metastasis.
    Hosokawa I; Takayashiki T; Kuboki S; Takano S; Togasaki K; Miyazaki M; Ohtsuka M
    Surgery; 2023 Jul; 174(1):11-20. PubMed ID: 37120380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis.
    Lenet T; Gilbert RWD; Smoot R; Tzeng CD; Rocha FG; Yohanathan L; Cleary SP; Martel G; Bertens KA
    Ann Surg Oncol; 2022 Nov; 29(12):7592-7602. PubMed ID: 35752725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment and prognostic factors in perihilar tumors.
    Polyakov AN; Patyutko YI; Kotelnikov AG; Frantsev DY; Korshak AV; Uzbekova AA; Egenov OA; Pokataev IA; Savchenko IV; Podluzhny DV
    Khirurgiia (Mosk); 2024; (2):14-23. PubMed ID: 38344956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and oncological benefits of left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma.
    Nakanishi Y; Hirano S; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Watanabe Y; Shichinohe T
    Surg Today; 2022 May; 52(5):844-852. PubMed ID: 34724106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of routine intraoperative frozen sections of proximal bile duct margins in perihilar cholangiocarcinoma, a retrospective multicenter and matched case-control study.
    Nooijen LE; Franken LC; de Boer MT; Buttner S; van Dieren S; Koerkamp BG; Hoogwater FJH; Kazemier G; Klümpen HJ; Kuipers H; Olthof PB; Swijnenburg RJ; Verheij J; Zonderhuis BM; van Gulik TM; Erdmann JI
    Eur J Surg Oncol; 2022 Dec; 48(12):2424-2431. PubMed ID: 35729016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of positive proximal margin after resection for hilar cholangiocarcinoma: An analysis of 42 cases.
    Öter V; Özer İ; Dalgıç T; Binarbaşı C; Ulaş M; Bostancı EB
    Turk J Gastroenterol; 2019 Jan; 30(1):88-94. PubMed ID: 30301710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
    Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
    Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
    Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
    Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radical surgery for hilar cholangiocarcinoma (Klatskin tumor)].
    Ramos Rubio E
    Cir Esp; 2007 Jul; 82(1):11-5. PubMed ID: 17580025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma.
    Conci S; Viganò L; Ercolani G; Gonzalez E; Ruzzenente A; Isa G; Salaris C; Fontana A; Bagante F; Pedrazzani C; Campagnaro T; Iacono C; De Santibanes E; Pinna DA; Torzilli G; Guglielmi A
    Eur J Surg Oncol; 2020 Sep; 46(9):1727-1733. PubMed ID: 32360063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.